From Nasdaq: 2025-02-12 11:51:13

Hims & Hers (NYSE: HIMS) launched a Super Bowl ad, facing opposition from pharmaceutical companies and pharmacists. Analyst Travis Hoium sees this as a sign of the company’s disruptive potential. Stock prices as of Feb. 11, 2025, and video published on Feb. 12, 2025.

Invest $1,000 in the 10 best stocks our analyst team recommends. Don’t miss this second chance for lucrative opportunities. Get in on our “Double Down” stock recommendations for companies like Nvidia and Apple, with past investment returns of up to $344,352. Three new “Double Down” alerts are available now.

Former Whole Foods Market CEO John Mackey is a board member of The Motley Fool. Travis Hoium has positions in Hims & Hers Health. The Motley Fool recommends Amazon and has a disclosure policy. Travis Hoium is affiliated with The Motley Fool but maintains independent opinions. Subscribe through their link to support their channel.



Read more at Nasdaq: Why Hims & Hers Terrifies Big Pharma